Oral fluoropyrimidines in the treatment of colorectal cancer
- 1 September 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10) , 1509-1513
- https://doi.org/10.1016/s0959-8049(98)00226-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal CancerJNCI Journal of the National Cancer Institute, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Circadian cancer therapy.Journal of Clinical Oncology, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)Cancer Treatment Reviews, 1980
- Phase ii evaluation of ftorafur in previously untreated colorectal cancer: A southwest oncology group studyCancer, 1979
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957